CUSIP: 62818Q104
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,943,694
-
Share change
-
-2,234,372
-
Total reported value
-
$4,707,199
-
Put/Call ratio
-
0.42%
-
Price per share
-
$0.39
-
Number of holders
-
58
-
Value change
-
-$932,068
-
Number of buys
-
17
-
Number of sells
-
35
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 62818Q104:
Institutional Holders of MUSTANG BIO INC - COM (MBIO) as of Q4 2022
As of 31 Dec 2022,
MUSTANG BIO INC - COM (MBIO) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,943,694 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Laurion Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, Telemetry Investments, L.L.C., ACADIAN ASSET MANAGEMENT LLC, HighTower Advisors, LLC, and MORGAN STANLEY.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.